Have we told you already that we know a thing or two about biopharma? Well, here goes.
We are very proud to announce that we have signed a book publishing contract with one of the most reputable publishers in the world, Palgrave MacMillan (www.palgrave.com). With offices in New York, Londen, and Shanghai, Palgrave Macmillan -now part of Springer Nature- is a globally acclaimed publisher in business and management and has 170+ years of publishing expertise. Agio Capital and Palgrave will work together to publish our insights and expert knowledge about dealmaking and fundraising in the biopharma sector in China.
The book’s release is expected in Spring 2024 and will be available in all market markets in the world.
